DES

USPTO Trademark Record

REGISTERED

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS

Q: Who owns the DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark?

The DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark is owned by Gilead Sciences Ireland UC.

Q: What class is the DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark registered in?

The DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Q: What is the serial number for DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS?

The USPTO serial number for DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS is 88615918.

SN 88615918·Reg 6414007·Filed Sep 13, 2019

Owner Gilead Sciences Ireland UC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS (Serial No. 88615918), Registration No. 6414007, is a registered US trademark filed on Sep 13, 2019 by Gilead Sciences Ireland UC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Section 8/9 declaration window: July 14, 2031

Mark Intelligence

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS (Reg. #6414007) is a registered US trademark that has been protecting its owner, Gilead Sciences Ireland UC, since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 13, 2019

SERIAL

88615918

REG#

6414007

REGISTERED

Jul 13, 2021

Owner

Applicant

Gilead Sciences Ireland UC

Entity

Not Provided

Address

IDA BUSINESS AND TECHNOLOGY PARK, CARRIGTOHILL, CO. CORK

Country

Attorney

NameDanielle Feria

Law firm

Danielle Feria Gilead Sciences, Inc.

Docket

10026-US-NF

Address

333 LAKESIDE DRIVE, Foster City, CA 94404, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 13, 2019

Serial Number88615918

Registration No.6414007

Registration DateJul 13, 2021

Status DateOct 01, 2026

Published for OppositionNov 03, 2020

Next RenewalJuly 14, 2031

Mark TypeDesign with words

Attorney Docket10026-US-NF

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

43 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 01, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 01, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Oct 01, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Jul 14, 2026

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 13, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 10, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 10, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 10, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 10, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 10, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jul 13, 2021

REGISTERED-PRINCIPAL REGISTER

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 04, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

1(B) BASIS DELETED; PROCEED TO REGISTRATION

Jun 04, 2021

1(B) BASIS DELETED; PROCEED TO REGISTRATION

NOTICE OF ALLOWANCE CANCELLED

May 03, 2021

NOTICE OF ALLOWANCE CANCELLED

TEAS DELETE 1(B) BASIS RECEIVED

May 03, 2021

TEAS DELETE 1(B) BASIS RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 29, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 03, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 03, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 14, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ELECTRONIC RECORD REVIEW COMPLETE

Sep 29, 2020

ELECTRONIC RECORD REVIEW COMPLETE

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Sep 25, 2020

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

EXAMINER'S AMENDMENT ENTERED

Sep 22, 2020

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT E-MAILED

Sep 22, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 22, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Sep 22, 2020

EXAMINERS AMENDMENT -WRITTEN

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 22, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 01, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 01, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Aug 26, 2020

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 06, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Apr 06, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 06, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 06, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 12, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 12, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Dec 21, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 21, 2019

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 21, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 14, 2019

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 24, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 23, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 17, 2019

NEW APPLICATION ENTERED

DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Gilead Sciences Ireland UC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Danielle Feria

Resources

Company